© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 24, 2107-2111,
December 15, 1999
© 1999 Oxford University Press
REPORTS |
HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years
Affiliations of authors: F. A. Firgaira, R. Seshadri, C. R. E. McEvoy, Department of Haematology and Genetic Pathology, Flinders University and Flinders Medical Centre, Bedford Park, South Australia; G. S. Dite, J. L. Hopper, The University of Melbourne, Centre for Genetic Epidemiology, Carlton, Victoria, Australia; G. G. Giles, Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Carlton, Australia; M. R. E. McCredie, Cancer and Epidemiology Research Unit, New South Wales Cancer Council, Kings Cross, Australia, and Department of Preventative and Social Medicine, University of Otago, New Zealand; M. C. Southey, D. J. Venter, Department of Pathology and Research, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia, and Department of Pathology, The University of Melbourne, Parkville, Australia.
Correspondence to: John L. Hopper, Ph.D., The University of Melbourne, Centre for Genetic Epidemiology, 200 Berkeley St., Carlton, Victoria 3053, Australia (e-mail: j.hopper{at}gpph.unimelb.edu.au).
BACKGROUND: A recent meta-analysis of 23 studies supported the empirically derived hypothesis that women who lack one of the four common minisatellite alleles at the HRAS1 locus are at increased risk of breast cancer. These studies relied on visual sizing of alleles on electrophoretic gels and may have underreported rare alleles. We determined whether this hypothesis applied to early-onset breast cancer by using a new method to size minisatellite alleles. METHODS: We conducted a population-based, case-control-family study of 249 Australian women under 40 years old at diagnosis of a first primary breast cancer and 234 randomly selected women, frequency matched for age. We sized HRAS1 minisatellite alleles with an Applied Biosystems model 373 automated DNA sequencer and GENESCANTM software. All P values are two-sided. RESULTS: We found no association of rare alleles with breast cancer, before or after adjustment for risk factors and irrespective of how their effects were modeled (crude odds ratio = 1.04; 95% confidence interval [CI] = 0.071-1.53; P = .8). The rare allele frequency was 0.173 (95% CI = 0.149-0.197), three times the pooled estimate of 0.058 (95% CI = 0.050-0.066) from previous studies (P<.001), and was similar for case subjects, 0.177 (95% CI = 0.143-0.221), and control subjects, 0.169 (95% CI = 0.135-0.203) (P = .7). CONCLUSION: There was no support for an association between rare HRAS1 alleles and the risk of early-onset breast cancer, despite 80% power to detect effects of the magnitude of those associations (1.7-fold) previously suggested. IMPLICATIONS: The question of whether cancer risk is associated with rare minisatellite HRAS1 alleles needs to be revisited with the use of new methods that have a greater ability to distinguish rare alleles from similarly sized common alleles.
This article has been cited by other articles:
![]() |
F. Farassati, W. Pan, F. Yamoutpour, S. Henke, M. Piedra, S. Frahm, S. Al-Tawil, W. I. Mangrum, L. F. Parada, S. D. Rabkin, et al. Ras Signaling Influences Permissiveness of Malignant Peripheral Nerve Sheath Tumor Cells to Oncolytic Herpes Am. J. Pathol., December 1, 2008; 173(6): 1861 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. A. Ioannidis Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. J Natl Cancer Inst, October 4, 2006; 98(19): 1350 - 1353. [Full Text] [PDF] |
||||
![]() |
O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Tamimi, S. E. Hankinson, S. Ding, V. Gagalang, G. P. Larson, D. Spiegelman, G. A. Colditz, T. G. Krontiris, and D. J. Hunter The HRAS1 Variable Number of Tandem Repeats and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1528 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Langdon and J. A.L. Armour Evolution and population genetics of the H-ras minisatellite and cancer predisposition Hum. Mol. Genet., April 15, 2003; 12(8): 891 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Krontiris Re: HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years J Natl Cancer Inst, May 3, 2000; 92(9): 755a - 756a. [Full Text] [PDF] |
||||




